title: First monoclonal antibody biosimilars: tackling the challenge of substitution.
authors.affiliation: a Faculty of Pharmacy , Paris Descartes University, Sorbonne Paris Cité , Paris , France ;|b Health Law Institute, Inserm, UMR S 1145, Paris Descartes University, Sorbonne Paris Cité , Paris , France ;|c General Agency of Equipment and Health Products (AGEPS) , Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris , France.
authors.forename: François
authors.initials: F
authors.lastname: Bocquet
authors.affiliation: a Faculty of Pharmacy , Paris Descartes University, Sorbonne Paris Cité , Paris , France ;|b Health Law Institute, Inserm, UMR S 1145, Paris Descartes University, Sorbonne Paris Cité , Paris , France ;|c General Agency of Equipment and Health Products (AGEPS) , Assistance Publique-Hôpitaux de Paris (AP-HP) , Paris , France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Paubel
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics*; D059451:Biosimilar Pharmaceuticals / Q000191:economics*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D057915:Drug Substitution / Q000191:economics*; D004465:Economic Competition; D005060:Europe; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals